KARAS ERIC (Chief Commercial Officer) sold 67.2% of their position (25K shares) of ARS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $250.0K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/13/2026ACC: 0001951287-26-000004
Officer· Chief Commercial Officer
Since Nov 2022
-25K
Net shares
Net seller
$250.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
25K acquired · 50K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+25K
Price / share
$1.50
Trade value
$37.50K
% of position
205.3%
6/12/2026
12.18K→37.18K
Common Stock
Direct
Shares
−25K
Price / share
$10.00
Trade value
$250K
% of position
67.2%
6/12/2026
37.18K→12.18K
Total
Net shares
+0.00
Net value
-$212.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/12/2026 | M · Option Exercise | +25K | $1.50 | $37.50K | 205.3% | 12.18K | 37.18K |
| Common Stock Direct | 6/12/2026 | S · Sale | −25K | $10.00 | $250K | 67.2% | 37.18K | 12.18K |
| Total | +0.00 | -$212.50K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
25K shares
Shares
−25K
Strike price
1.50
Held after
519.59K
Exercisable
—
6/12/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock25K shares | 6/12/2026 | M · Option Exercise | −25K | 1.50 | — | 519.59K |